Idexx Laboratories (IDXX) Stock Price, Quote & News

Company Profile

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. It operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. The company offers point-of-care diagnostic solutions, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology/morphology, and coagulation analyzers; and...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 207 556 0300

Fax: 207 556 4346

Website: www.idexx.com

Address:

One IDEXX Drive, Westbrook, United States

MyChicago Mar. 18 at 7:10 PM

$ZOMDF $IDXX : Built in‑clinic diagnostic platforms Created recurring consumables Locked in veterinary practices Expanded globally Focused on execution, not hype Sound familiar? HESKA was bought out by Mars a prive a company.

1 · Reply

MyChicago Mar. 18 at 4:17 PM

$ZOMDF $ZOMDF $IDXX Zomedica now runs a multi‑product veterinary platform — TRUFORMA, TRUVIEW, PulseVet, VETIGEL, Assisi Loop, VetGuardian — backed by partners like Boehringer Ingelheim, Qorvo, Moichor, Grovet, Cresilon, and BAW. That’s execution. That’s scale.

0 · Reply

MyChicago Mar. 18 at 1:38 PM

$ZOMDF Zomedica vs IDEXX Equine Diagnostics $IDXX IDEXX (Traditional Model): Centralized reference labs Send‑out testing Slower turnaround Less control for the clinic Zomedica + Boehringer (Modern Model): In‑clinic endocrine testing Same‑day results Ongoing monitoring revenue Integrated into treatment decisions IDEXX dominates labs. Zomedica is attacking point‑of‑care, where speed and workflow matter most. Different lanes — and Zomedica just got a global partner to help run theirs.

0 · Reply

Lambition Mar. 17 at 4:19 AM

$ZOMDF $BTC.X $SPY $GS $IDXX https://stocks.apple.com/Aa3cVWwYpR7u_ifLzHZzwgQ

0 · Reply

SuperGreenToday Mar. 11 at 1:28 PM

$IDXX Share Price: $598.63 Contract Selected: Oct 16, 2026 $610 Calls Buy Zone: $66.03 – $81.57 Target Zone: $105.53 – $128.99 Potential Upside: 51% ROI Time to Expiration: 218 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

ZacksResearch Mar. 9 at 7:11 PM

$IDXX up 39% in a year — and the momentum isn’t random. CAG Diagnostics’ recurring revenues, ongoing diagnostic innovations, and software growth are fueling the run, helping push shares up 39% over the past year. 🚀 Discover what’s driving the surge 👉 https://www.zacks.com/stock/news/2881137/idexx-laboratories-stock-climbs-394-in-a-year-whats-driving-it?cid=sm-stocktwits-2-2881137-teaser-36644&ADID=SYND_STOCKTWITS_TWEET_2_2881137_TEASER_36644

0 · Reply

ZacksResearch Mar. 9 at 6:11 PM

$IDXX surges 39.4% over the last 12 months — what’s fueling this rally? 🚀 📈 CAG Diagnostics’ recurring revenues up 10% organically in Q4 2025 🔬 Innovations like Cancer Dx panel and inVue Dx gaining traction 🌍 Expanding global commercial footprint enhances growth potential See what makes the investment case strong for IDXX 👉 https://www.zacks.com/stock/news/2881137/idexx-laboratories-stock-climbs-394-in-a-year-whats-driving-it?cid=sm-stocktwits-2-2881137-body-36645&ADID=SYND_STOCKTWITS_TWEET_2_2881137_BODY_36645

0 · Reply

Villidj_Idjit Mar. 8 at 4:48 AM

$IDXX possible bullish divergence.

0 · Reply

ZacksResearch Mar. 6 at 2:11 PM

Hold or fold $IDXX right now? 🤔 Investors are asking whether this is the right moment to retain the stock in their portfolios, putting the spotlight on the current investment case and what it means for positioning going forward. Find out whether holding the stock still makes sense 👉 https://www.zacks.com/stock/news/2880023/is-this-the-right-time-to-retain-idxx-stock-in-your-portfolio?cid=sm-stocktwits-2-2880023-teaser-36291&ADID=SYND_STOCKTWITS_TWEET_2_2880023_TEASER_36291

0 · Reply

MyChicago Feb. 25 at 4:19 PM

$ZOMDF $IDXX. New partner and distribution contracts with Moichor for ZOMEDICA announced today. CEO was also with IDXX for many years. Great New. BULLISH.

0 · Reply

Baron Growth Fund Q4 2025 Contributors And Detractors

ACGL CHH CSGP FIGS GWRE KNSL MSCI

Mar 2, 2026, 11:47 AM EST - 19 days ago

IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript

Feb 26, 2026, 1:27 PM EST - 23 days ago

IDEXX Laboratories, Inc. (IDXX) Presents at BofA Securities Animal Health Summit Transcript

Feb 17, 2026, 1:36 AM EST - 4 weeks ago

Baron Partners Fund Q4 2025 Contributors And Detractors

CSGP GWRE H IT MTN SPOT TSLA

Feb 12, 2026, 4:15 PM EST - 5 weeks ago

IDEXX Laboratories to Present at Two Institutional Investor Conferences

Feb 3, 2026, 10:12 AM EST - 6 weeks ago

IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results

Feb 2, 2026, 11:40 AM EST - 6 weeks ago

IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript

Feb 2, 2026, 8:12 AM EST - 6 weeks ago

IDEXX forecasts 2026 revenue, profit above estimates on strong demand for pet diagnostics

Feb 2, 2026, 6:30 AM EST - 6 weeks ago

IDEXX Laboratories Announces Fourth Quarter and Full Year 2025 Results

Jan 25, 2026, 10:09 AM EST - 7 weeks ago

Conestoga Mid Cap Composite Q4 2025 Leaders And Laggards

BSY CSGP GNRC JKHY POOL RGEN ROL

Jan 15, 2026, 12:30 PM EST - 2 months ago

MoneyShow's Best Investment Ideas For 2026: Part 5

HRL HUT IONQ KDK MNKD

Jan 15, 2026, 7:15 AM EST - 2 months ago

Lowest-Dose Radiography Meets Next-Level Imaging: IDEXX Launches ImageVue DR50 Plus

Jan 15, 2026, 7:00 AM EST - 2 months ago

IDEXX Advances the Future of Veterinary Cancer Care with Comprehensive Mast Cell Tumor Testing for Dogs

Jan 13, 2026, 8:30 AM EST - 2 months ago

IDEXX Announces CEO Succession

Jan 9, 2026, 1:30 PM EST - 2 months ago

IDEXX Laboratories to Release 2025 Fourth Quarter and Full Year Financial Results

Jan 7, 2026, 1:51 PM EST - 2 months ago

Final Trades: Palo Alto Networks, Capital One, Idexx Labs and the XLB

COF PANW XLB

Nov 24, 2025, 2:15 PM EST - 4 months ago

IDEXX Laboratories Vs ResMed: Which Stock Could Rally?

RMD

Nov 13, 2025, 2:30 AM EST - 4 months ago

Baron Asset Fund Q3 2025 Performance Review

APH CHH FDS IT MORN ONON STUB

Nov 4, 2025, 5:31 AM EST - 4 months ago

IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects

Nov 3, 2025, 1:29 PM EST - 4 months ago

Final Trades: Meta, S&P Global and Idexx Lab

META SPGI

Nov 3, 2025, 11:36 AM EST - 4 months ago

IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 11:08 AM EST - 4 months ago

Idexx Stock Pops on Earnings. Pet Health Is Booming.

Nov 3, 2025, 10:55 AM EST - 4 months ago

Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook

Nov 3, 2025, 7:43 AM EST - 4 months ago

IDEXX raises annual forecasts as pet owners spend more on preventive care

Nov 3, 2025, 6:30 AM EST - 4 months ago

IDEXX Laboratories Announces Third Quarter Results

Nov 3, 2025, 1:01 AM EST - 4 months ago

IDEXX Laboratories Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Oct 8, 2025, 2:00 PM EDT - 5 months ago

IDEXX Laboratories to Release 2025 Third Quarter Financial Results

Oct 7, 2025, 7:00 AM EDT - 5 months ago

IDEXX Laboratories Elects Karen Peacock to Board of Directors

Sep 9, 2025, 5:24 PM EDT - 6 months ago

IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 2, 2025, 1:00 PM EDT - 7 months ago

IDEXX Laboratories to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 7, 2025, 9:35 PM EDT - 8 months ago

Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts

ARGX COO ELV HQY INSM ISRG RDNT

Aug 4, 2025, 5:55 PM EDT - 8 months ago

S&P 500 Gains and Losses Today: Retail Sector Stocks Rise Amid Rate Cut Hopes

Aug 4, 2025, 2:37 PM EDT - 8 months ago

IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:48 PM EDT - 8 months ago

Final Trades: Delta Air Lines, Tesla, Idexx Lab and the IYF

DAL IYF TSLA

Aug 4, 2025, 12:15 PM EDT - 8 months ago

Top Stock Movers Now: IDEXX, Wayfair, Berkshire Hathaway, and More

Aug 4, 2025, 10:45 AM EDT - 8 months ago

IDEXX Surpasses Earnings Expectations, Justifying Premium Valuation

Aug 4, 2025, 9:10 AM EDT - 8 months ago

IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook

Aug 4, 2025, 7:57 AM EDT - 8 months ago

IDEXX Laboratories raises annual forecasts on strong demand for pet diagnostics

Aug 4, 2025, 6:30 AM EDT - 8 months ago

IDEXX Laboratories Announces Second Quarter Results

Jul 30, 2025, 7:00 AM EDT - 8 months ago

IDEXX Releases 2024 Corporate Responsibility Report, Highlighting Progress Against Its Goals

Jul 17, 2025, 7:06 AM EDT - 8 months ago

IDEXX Laboratories: A Business With Strong Fundamentals

Jul 10, 2025, 7:00 AM EDT - 9 months ago

IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors

Jun 24, 2025, 1:00 PM EDT - 9 months ago

IDEXX Laboratories to Release 2025 Second Quarter Financial Results

Jun 5, 2025, 7:00 AM EDT - 10 months ago

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders

May 14, 2025, 2:35 PM EDT - 11 months ago

IDEXX Laboratories: Growth Remains Despite Weak Clinical Visits

May 13, 2025, 2:30 PM EDT - 11 months ago

IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day

May 1, 2025, 10:35 AM EDT - 11 months ago

IDEXX Laboratories, Inc. (IDXX) Q1 2025 Earnings Conference Call Transcript

May 1, 2025, 8:21 AM EDT - 11 months ago

IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics

May 1, 2025, 6:30 AM EDT - 11 months ago

IDEXX Laboratories Announces First Quarter Results

Apr 3, 2025, 1:30 PM EDT - 1 year ago

IDEXX Laboratories to Release 2025 First Quarter Financial Results

MyChicago Mar. 18 at 7:10 PM

1 · Reply

MyChicago Mar. 18 at 4:17 PM

0 · Reply

MyChicago Mar. 18 at 1:38 PM

0 · Reply

Lambition Mar. 17 at 4:19 AM

$ZOMDF $BTC.X $SPY $GS $IDXX https://stocks.apple.com/Aa3cVWwYpR7u_ifLzHZzwgQ

0 · Reply

SuperGreenToday Mar. 11 at 1:28 PM

0 · Reply

ZacksResearch Mar. 9 at 7:11 PM

0 · Reply

ZacksResearch Mar. 9 at 6:11 PM

0 · Reply

Villidj_Idjit Mar. 8 at 4:48 AM

$IDXX possible bullish divergence.

0 · Reply

ZacksResearch Mar. 6 at 2:11 PM

0 · Reply

MyChicago Feb. 25 at 4:19 PM

$ZOMDF $IDXX. New partner and distribution contracts with Moichor for ZOMEDICA announced today. CEO was also with IDXX for many years. Great New. BULLISH.

0 · Reply

MyChicago Feb. 25 at 4:11 PM

$ZOMDF $IDXX CEO of Moichor. Also was with IDXX for many years. Great fit for Zomedic. https://rocketreach.co/joseph-faiella-email_6078647

0 · Reply

MyChicago Feb. 25 at 2:39 PM

$ZOMDF $IDXX New Distribution deal with Moichor. Possibility for ZOMDF to manufacture also. Just a thought. distribution deals sometimes evolve into deeper supply arrangements (OEM, private‑labeling, or contract manufacturing) if both parties agree to scale production, share tooling, or consolidate supply chains. If Zomedica already has manufacturing capacity for similar devices — a company that already manufactures related hardware could be a logical partner to produce co‑branded units

1 · Reply

MyChicago Feb. 25 at 2:11 PM

$ZOMDF $IDXX

1 · Reply

MyChicago Feb. 25 at 2:07 PM

$ZOMDF Expands National Distribution with Moichor : CEO Of Moichor. 13 Years at $IDXX

1 · Reply

Wisenheimer Feb. 25 at 1:33 PM

$ZOMDF hmmmm Moicher CEO previously spent 13yrs at $IDXX

2 · Reply

TechniTraderEducation Feb. 24 at 5:44 PM

$IDXX Volatility ≠ chaos. If you know the signals, it’s opportunity. Full chart breakdown on TradingView: https://www.tradingview.com/chart/IDXX/Kho1I5hx-Solve-The-Problem-pf-Trading-in-a-Volatile-Market/ #Stocks #SwingTrading #MarketStructure #VolatilityTrading

0 · Reply

Sashko2018 Feb. 24 at 1:47 PM

$IDXX

0 · Reply

RumbleTrump Feb. 23 at 10:20 PM

$AIDX look at $IDXX If AIDX works out we could be millionaire

0 · Reply

RiskOverseer Feb. 18 at 4:47 PM

$IDXX IDEXX Laboratories provides diagnostics for animal health. Recurring revenue and pricing power support valuation. Growth is steady and defensive.

0 · Reply

OfficialStocktwitsUser Feb. 18 at 11:59 AM

$IDXX RSI: 24.57, MACD: -17.9994 Vol: 27.63, MA20: 660.30, MA50: 684.55 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZomedicaPharm Feb. 18 at 9:55 AM

$ZOMDF $IDXX

1 · Reply

Market Cap	45.89B
Revenue (ttm)	4.30B
Net Income (ttm)	1.06B
EPS (ttm)	N/A
PE Ratio	44.16
Forward PE	39.66
Profit Margin	24.62%
Debt to Equity Ratio	0.28

Volume	765,300
Avg Vol	522,720
Day's Range	N/A - N/A
Shares Out	79.52M
Stochastic %K	23%
Beta	1.66
Analysts	Strong Sell
Price Target	$773.58